top of page

Re-engineering how the world recovers metals.

Industrial biotechnology for the recovery of strategic materials from waste streams.

The Material Constraints

Modern industry depends on a narrow set of metals with fragile, energy-intensive supply chains.


At the same time, electronic waste is growing faster than any other waste stream — containing significant untapped material value.

Biological Approach to Materials recovery

Midas Biotech develops biological extraction systems designed to recover critical metals from complex electronic waste streams with lower energy intensity and greater process control than conventional methods.

Why this scales

  • Reduced reliance on high-temperature and chemically intensive processes.

  • Modular systems adaptable to different waste volumes.

  • Alignment with regulatory, supply-chain, and resource-security pressures.

Our Focus: Electronic Waste

The current application focuses on electronic waste, where metal density, regulatory pressure, and supply volatility intersect.
Providing a practical pathway for validation, optimisation, and scale.

​

Targeting:

​

- Biological extraction.
- Low-energy processing.
- Closed-loop workflows.
- High yield recovery.

Development Roadmap

Controlled progression from laboratory validation to industrial deployment

Our Timeline

Phase I - Foundation (2025)

Laboratory validation & system definition

  • Development and validation of biological extraction workflows

  • Feedstock characterisation and process repeatability testing

  • Early yield, selectivity, and energy-efficiency benchmarking

Phase II - Optimisation (2026)

Process refinement & scale readiness

  • Partner and Vendor relationship development

  • Process optimisation for stability, throughput, and recovery efficiency

  • Closed-loop workflow refinement and waste minimisation

  • Preparation for pilot-scale evaluation and external validation

Phase III - Deployment (2027+)

Pilot deployment & commercial pathway

  • Pilot-scale system evaluation

  • Assessment of deployment models and facility integration

  • Route to industrial deployment and early commercial partnerships

Get to Know Us

Founded in 2024, Midas Biotech operates at the intersection of industrial biotechnology, materials science, and infrastructure development.
The company focuses on building scalable biological systems for materials recovery.

About
Midas Biotech

bottom of page